首页> 外文期刊>The Internet Journal of Anesthesiology >Comparative Study of Single Dose Intravenous Ondansetron and Metoclopramide as a Premedication for Prevention of Post Operative Nausea and Vomiting in Obstetrical Laparoscopic Surgery under General Anaesthesia
【24h】

Comparative Study of Single Dose Intravenous Ondansetron and Metoclopramide as a Premedication for Prevention of Post Operative Nausea and Vomiting in Obstetrical Laparoscopic Surgery under General Anaesthesia

机译:全身麻醉下单剂量静脉使用恩丹西酮和甲氧氯普胺预防产科腹腔镜手术后恶心和呕吐的预防措施的比较研究

获取原文
       

摘要

Post Operative Nausea Vomiting (PONV) is the most unpleasant and distressing consequence in the immediate post-operative period especially after general anesthesia. PONV can delay discharge and may result in unplanned over night hospital admissions. This is prospective randomized control study of 60 ASA grade I/II patients recruited at Seth G.S. Medical College to find out the efficacy, duration of action, haemodynamic stability, side effects of ondansetran and metclopromide lower the incidence of PONV in 24 hr of post operative period. The study was undertaken with an aim to investigate 1) The nausea and vomiting in immediate post operative period. 2) Efficacy of single dose I.V. injection of ondansetran (4mg) and metclopromide on PONV and 3) Side effects of these drugs. Early antiemetic efficacy abolition of vomiting after 1 , 4, 12 hrs was 3.66, 10 and 3.33% respectively from the administration of the study drugs with no further vomiting or nausea episodes after 24 hrs was in the ondansetron group. Similarly, abolition of vomiting after 1 , 4, 12 and 24 hrs was 20, 20 ,16.66 and 3.33 % respectively in the metoclopramide group compared to the placebo group (P < 0.001). This difference was still significant when controlling for age, body weight, history of motion sickness, previous PONV episodes, duration of anesthesia, and intraoperative fentanyl consumption using a logistic model. Therefore the overall results indicated that ondansetran is more effective than metchlopromide for the prevention of PONV. Introduction Pain is not always the patients prime concern in the post operative period, many patients will take nausea and vomiting as the most unpleasant consequence. The number of drugs introduced for the relief of post operative pain have been largely successful but the same cannot be appliable for PONV (Post-operative Nausea and Vomiting).PONV is associated with general anaesthesia (GA) ever since the ether and chloroform era and the reported incidence were reported to be 75-80%. It still remains a problem, despite an evident clinical perception that its severity has diminished with an estimated incidence of 20-50%. PONV has consequence more far reaching than hitherto appreciated. It affects the patients in more ways than one and they may be stated as physical, metabolic, psychological and economic.There are a number of factors influencing the occurrence of PONV which includes Patient factors (Age, gender, obesity, anxiety, history of motion sickness or previous post and vomiting, gastro paresis); Operative procedures; Anesthetic techniques (Drugs for general anesthesia, regional anesthesia and monitored anesthesia care) and Post-operative factors (Pain, dizziness, ambulation, oral in-take, opioids)Laparoscopic surgery is the one condition, where risk of PONV is particularly pronounced. This technique first gained popularity with it use in gynecologic procedures that began in 1970. The patient group in this study was predominantly young. Early ambulation and decreased morbidity due to this technique rendered it increasingly popular. This increases the risk of PONV, which is due to pneumo-peritoneum-causing stimulation of mechanoreceptors in the gut. To reduce the incidence of PONV various pharmacological and non-pharmacological methods have been employed since the advent of anesthesia. Ondansetron is a specific 5 – HT3 subtype receptor antagonist and represents a major improvement in chemotherapy and radiation therapy induced nausea and vomiting. Metoclopramide is a dopamine antagonist acting on the CTZ. It is a gastrointestinal tract (GIT) prokinetic drug. It increases lower esophageal sphincter tone and stimulates motility of the upper GIT. This study endeavors to compare the efficacy of ondansetron and metoclopramide in prevention of PONV when given as a single dose of intravenous (i.v.) premedication in obstetrical laparoscopic surgery under GA. The incidence of side-effects was also noted. Materials and methods Follo
机译:术后恶心呕吐(PONV)是术后特别是在全身麻醉后最令人不快和困扰的结果。 PONV可能会延迟出院,并可能导致夜间计划外住院。这是一项对60例在Seth GS Medical College招募的ASA I / II级ASA患者进行的前瞻性随机对照研究,以了解其疗效,作用时间,血流动力学稳定性,恩丹西坦和甲氯普鲁胺的副作用降低术后24小时PONV的发生期。进行该研究的目的是调查1)术后即刻的恶心和呕吐。 2)单剂量静脉内注射的功效注射ondansetran(4mg)和甲氯普鲁米对PONV和3)这些药物的副作用。恩丹西酮组在服用本研究药物后的1、4、12小时后的早期止吐功效分别为3.66%,10%和3.33%,而没有进一步呕吐或恶心发作。同样,与安慰剂组相比,甲氧氯普胺组在1、4、12和24小时后的呕吐消除率分别为20%,20%,16.66%和3.33%(P <0.001)。当使用逻辑模型控制年龄,体重,运动病史,以前的PONV发作,麻醉时间和术中服用芬太尼时,这种差异仍然很明显。因此,总体结果表明,恩丹西兰在预防PONV方面比甲氧氯普胺更有效。简介疼痛并不是术后患者的首要关注,许多患者会以恶心和呕吐为最不愉快的后果。自从以太和氯仿时代以来,PONV与全身麻醉(GA)有关,PONV与全身麻醉(GA)有关,因此,为缓解术后疼痛而引入的药物数量已大获成功,但不适用于PONV(术后恶心和呕吐)。报告的发病率据报道为75-80%。尽管仍然有明显的临床感觉,其严重程度有所降低,估计仍为20-50%,但仍然是一个问题。 PONV带来的影响远远超过了迄今为止的认识。它以多种方式影响患者,可以说是身体,代谢,心理和经济因素。影响PONV发生的因素有很多,包括患者因素(年龄,性别,肥胖,焦虑,运动史)。疾病或以前的职务和呕吐,胃轻瘫);手术程序;麻醉技术(全身麻醉,局部麻醉和监督麻醉护理药物)和术后因素(疼痛,头晕,行走,口服,阿片类药物)是腹腔镜手术的一种情况,其中PONV的风险特别明显。这项技术首先在1970年开始应用于妇科手术中就获得了普及。本研究的患者组主要是年轻的。由于这项技术的早期活动和发病率的降低,使其越来越受欢迎。这增加了PONV的风险,这是由于引起肠内机械感受器的肺气腹膜刺激所致。为了降低PONV的发生率,自麻醉开始以来,已采用了各种药理和非药理方法。恩丹西酮是一种特殊的5-HT3亚型受体拮抗剂,代表了化学疗法和放射疗法引起的恶心和呕吐的重大改善。甲氧氯普胺是作用于CTZ的多巴胺拮抗剂。它是胃肠道(GIT)的促动力药。它增加了食管下括约肌的张力并刺激了上消化道的运动。这项研究致力于比较在氨苄青霉素治疗的妇产科腹腔镜手术中单剂量静脉内(i.v.)处方药时,恩丹西酮和甲氧氯普胺预防PONV的功效。还注意到了副作用的发生率。材料和方法

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号